Abstract
The use of drugs for the treatment of child and adolescent behavioral problems in a residential setting dates from 1937, with Bradley’s report on the beneficial effects of the stimulant drug benzedrine on the school performance and conduct of a group of 30 boys and girls, ages 5 to 14 years. Since that time, psychopharmacotherapy has become an accepted and useful treatment modality in residential and hospital settings for children and adolescents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aman, M. G. (1984. Drugs and learning in mentally retarded persons. In G. D. Burrows & J. S. Werry (Eds.), Advances in human psychopharmacology (pp. 121–163). Greenwich: JAI Press.
Anderson, L. T., Campbell, M., Grega, D. M., Perry, R., Small, A. M., & Green, W. H. (1984). Haloperidol in the treatment of infantile autism: Effects on learning and behavioral symptoms. American Journal of Psychiatry, 141, 1195–1202.
Bartunkova, Z., Cerny, L. Ortilova, J., & Sturma, J. (1972). Propericiazin, diazepam, chlorpromazine and placebo in a double-blind trial in pedopsychiatric therapy. Activitas Nervosa Superior (Praha), 14, 83–84.
Bennett, W. G., Korein, J., Kalmijn, M., Grega, D. M., & Campbell, M. (1983). EEG and treatment of hospitalized aggressive children with haloperidol or lithium. Biological Psychiatry, 18, 1427–1440.
Bradley, C. (1937). The behavior of children receiving benzedrine. American Journal of Psychiatry, 94, 577–585.
Cade, J. F. J. (1949). Lithium salts in the treatment of psychotic excitement. Medical Journal of Australia, 36, 349–352.
Campbell, M., Adams, P., Small, A. M., Tesch, L. M., & Curren, E. L. (1988). Naltrexone in infantile autism. Psychopharmacology Bulletin, 24, 135–139.
Campbell, M., Anderson, L. T., Cohen, I. L., Perry, R., Small, A. M., Green, W. H., Anderson, L., & McCandless, W. (1982). Haloperidol in autistic children: Effects on learning, behavior and abnormal involuntary movements. Psychopharmacology Bulletin, 18, 110–112.
Campbell, M., Anderson, L. T., Small, A. M., Perry, R., Green, W. H., & Caplan, R. (1982). The effects of haloperidol on learning and behavior in autistic children. Journal of Autism and Developmental Disorders, 12, 167–175.
Campbell, M., Cohen, I., & Perry, R. (1983. Psychopharmacological treatment. In T. H. Ollendick & M. Hersen (Eds.), Handbook of child psychopathology (pp. 461–484). New York: Plenum Press.
Campbell, M., Cohen, I. L., Perry, R., & Small, A. M. (in press). Psychopharmacological treatment. In T. H. Ollendick & M. Hersen (Eds.), Handbook of child psychopathology. New York: Plenum Press.
Campbell, M., Cohen, I. L., & Small, A. M. (1982). Drugs in aggressive behavior. Journal of the American Academy of Child Psychiatry, 21, 107–117.
Campbell, M., Geller, B., & Cohen, I. L. (1977). Current status of drug research and treatment with autistic children. Journal of Pediatric Psychology, 2, 153–161.
Campbell, M., Green, W. H., & Deutsch, S. I. (1985). Child and adolescent psychopharmacology. Beverly Hills: Sage.
Campbell, M., Grega, D. M., Green, W. H., & Bennett, W. G. (1983). Neuroleptic-induced dyskinesias in children. Clinical Neuropharmacology, 6, 207–222.
Campbell, M., Perry, R., & Green, W. H. (1984). Use of lithium in children and adolescents. Psychosomatics, 25, 95–106.
Campbell, M., Small, A. M., Green, W. H., Jennings, S. J., Perry, R., Bennett, W. G., & Anderson, L. (1984). Behavioral efficacy of haloperidol and lithium carbonate: A comparison in hospitalized aggressive children with conduct disorder. Archives of General Psychiatry, 41, 650–656.
Campbell, M., Small, A. M., Palij, M., Perry, R., Polonsky, B. B., Lakashok, D., & Anderson, L. T. (1987). The efficacy and safety of fenfluramine in autistic children: Preliminary analysis of a double-blind study. Psychopharmacology Bulletin, 23, 123–127.
Cohen, D. J., Shaywitz, B. A., Young, J. G., Carbonari, C.M., Nathanson, J. A., Lieberman, D., Bowers, M. B., & Mass, J. W. (1979). Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette. Journal of the American Academy of Child Psychiatry, 18, 320–341.
Comings, D. E., & Comings, B. G. (1984). Tourette’s syndrome and attention deficit with hyperactivity: Are they genetically related? Journal of the American Academy of Child Psychiatry, 23, 138–146.
Connell, P. H., Corbett, J. A., Home, D. J., & Mathews, A. M. (1967). Drug treatment of adolescent tiguers: A double-blind trial of diazepam and haloperidol. British Journal of Psychiatry, 113, 375–381.
Conners, C. K. (1969). A teacher rating scale for use in drug studies with children. American Journal of Psychiatry, 126, 152–156.
Conners, C. K. (1985). Issues in the study of adolescent ADD-H/hyperactivity. Psychopharmacology Bulletin, 21, 243–250.
Conners, C. K., Kramer, R., Rothschild, G. H., Schwartz, L., & Stone, A. (1971). Treatment of young delinquent boys with diphenylhydantoin sodium and methylphenidate: A controlled comparison. Archives of General Psychiatry, 24, 156–162.
Conners, C. K., & Taylor, E. (1980). Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction. Archives of General Psychiatry, 21, 182–190.
Cunningham, M. A., Pillai, V., & Rogers, W. J. B. (1968). Haloperidol in the treatment of children with severe behavior disorders. British Journal of Psychiatry, 114, 845–854.
D’Amato, G. (1962). Chlordiazepoxide in management of school phobia. Diseases of the Nervous System, 23, 292–295.
DeLong, G. R., & Aldershof, A. L. (1987). Long-term experience with lithium treatment in childhood: Correlation with clinical diagnosis. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 389–394.
DeLong, G. R., & Nieman, G. W. (1983). Lithium-induced behavior changes in children with symptoms suggesting manic-depressive illness. Psychopharmacology Bulletin, 19, 258–265.
Denckla, M. B., Bemporad, J. R., & MacKay, M. C. (1976). Tics following methylphenidate administration: A report of 20 cases. Journal of the American Medical Association, 235, 1349–1351.
Deutsch, S.I. (1986a). Managing behavior in mentally retarded residential populations. Hospital and Community Psychiatry, 37, 221–222.
Deutsch, S.I. (1986b). Rationale for the administration of opiate antagonists in treating infantile autism. American Journal of Mental Deficiency, 90, 631–635.
Evans, B. W., Clay, T. H., & Gualtieri, T. (1987). Carbamazepine in pediatric psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 2–8.
Geller, B., & Greydanus, B. E. (1979). Haloperidol-induced comatose state with hyperthermia and rigidity in adolescence: Two case reports and a literature review. Journal of Clinical Psychiatry, 40, 102–103.
Gittelman, R., & Mannuzza, S. (1985). Diagnosing ADD-H in adolescents. Psychopharmacology Bulletin, 21, 237–242.
Gittelman-Klein, R., & Klein, D. F. (1973). School phobia: Diagnostic considerations in the light of imipramine effects. Journal of Nervous and Mental Disease, 156, 199–215.
Gittelman-Klein, R., Klein, D. F., Katz, S., Saraf, K. R., & Pollack, E. (1976). Comparative effects of methylphenidate and thioridazine in hyperkinetic children: I. Clinical results. Archives of General Psychiatry, 33, 1217–1231.
Glick, B. S., Schulman, D., & Turecki, S. (1971). Diazepam (Valium) treatment in childhood sleep disorders. Diseases of the Nervous System, 32, 565–566.
Green, W. H., Campbell, M., Wolsky, B. B., Deutsch, S. I., Golden, R. R., & Cicero, S. D. (October, 1984). Effects of short and long term haloperidol administration on growth in young autistic children. Paper presented at the 31st Annual Meeting of the American Academy of Child Psychiatry, Toronto.
Greenblatt, D. J., & Shader, B. I. (1974). Benzodiazepines in clinical practice. New York: Raven Press.
Greenhill, L. L., Rieder, R. O., Wender, P. H., Buchsbaum, M., & Zahn, T. P. (1973). Lithium carbonate in the treatment of hyperactive children. Archives of General Psychiatry, 28, 636–640.
Gualtieri, C. T., Quade, D., Hicks, R. E., Mayo, J. P., & Schroeder, S. R. (1984). Tardive dyskinesia and other clinical consequences of neuroleptics treatment in children and adolescents. American Journal of Psychiatry, 141, 20–23.
Herman, B. H., Hammock, M. K., Arthur-Smith, A., Egan, J., Chatoor, I., Zelnick, N., Appelgate, K., Beockx, R. L. (1986). Effects of naltrexone in autism: Correlation with plasma opioid concentrations. Scientific Proceedings for the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, 2, 11–12.
Kline, A. H. (1968). Diazepam and the management of nocturnal enuresis. Clinical Medicine, 75, 20–22.
Kraft, I. A., Ardali, C., Duffy, J. H., Hart, J. T., & Pearce, P. (1965). A clinical study of chlordiazepoxide used in psychiatric disorders of children. International Journal of Neuropsychiatry, 1, 433–437.
Krakowski, A. J. (1963). Chlordiazepoxide in treatment of children with emotional disturbances. New York State Journal of Medicine, 63, 3388–3392.
Lefkowitz, M. M. (1969). Effects of diphenylhydantoin on disruptive behavior. Archives of General Psychiatry, 20, 643–651.
Levenson, J. L. (1985). Neuroleptic malignant syndrome. American Journal of Psychiatry, 142, 1137–1145.
Lowe, T. L., Cohen, D. J., Detlor, J., Kremenitzer, M. W., & Shaywitz, B. A. (1982). Stimulant medications precipitate Tourette’s syndrome. Journal of the American Medical Association, 247, 1729–1731.
Lucas, A. R., & Pasley, F. C. (1969). Psychoactive drugs in treatment of emotionally disturbed children: Haloperidol and diazepam. Comprehensive Psychiatry, 10, 376–386.
Mattes, J., & Gittelman, R. (1983). Growth of hyperactive children on maintenance methylphenidate. Archives of General Psychiatry, 40, 317–321.
McNutt, B. A., Boileau, R. A., Cohen, M. N., Sprague, R. L., & von Neumann, A. (May, 1976). The effects of long term stimulant medication on the growth and body composition of hyperactive children: II. Report on 2 years. Paper presented at the Annual Early Clinical Drug Evaluation Unit Meeting, Psychopharmacology Research Branch, National Institute of Mental Health, Key Biscayne, FL.
Panksepp, J., & Sahley, T. L. (1987. Possible brain opioid involvement in disrupted social intent and language development in autism. In E. Schopler & G. B. Mesibov (Eds.), Neurobiological issues in autism (pp. 357–372). New York: Plenum Press.
Perry, R., Campbell, M., Adams, P., Lynch, N., Spencer, E. K., Curren, E. L., & Overall, S. E. (1989). Long-term haloperidol in autistic children: Continuous vs. discontinuous drug administration. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 87–92.
Perry, R., Campbell, M., Green, W. H., Small, A. M., Die Trill, M. L., Meiselas, K., Golden, R. R., & Deutsch, S. I. (1985). Neuroleptic-related dyskinesias in autistic children: A prospective study. Psychopharmacology Bulletin, 21, 140–143.
Pesikoff, R. B., & Davis, P. C. (1971). Treatment of pavor nocturnus and somnambulism in children. American Journal of Psychiatry, 128, 778–781.
Petti, T. A., & Campbell, M. (1975). Imipramine and seizures. American Journal of Psychiatry, 132, 538–540.
Petti, T. A., Fish, B., Shapiro, T., Cohen, I. L., & Campbell, M. (1982). Effects of chlordiazepoxide in disturbed children: A pilot study. Journal of Clinical Psychopharmacology, 2, 270–273.
Physicians Desk Reference. (1989). Oradell, NJ: Medical Economics Company.
Platt, J. E., Campbell, M., Green, W. H., & Grega, D. M. (1984). Cognitive effects of lithium carbonate and haloperidol in treatment-resistant aggressive children. Archives of General Psychiatry, 41, 657–662.
Pliszka, S. (1987). Tricyclic antidepressants in the treatment of children with attention deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 26, Mini.
Polakoff, S. A., Sorgi, P. J., & Ratey, J. J. (1986). The treatment of impulsive and aggressive behavior with nadolol. Journal of Clinical Psychopharmacology, 6, 125–126.
Pool, D., Bloom, W., Mielke, D. H., Roniger, J. J., & Gallant, D. M. (1976). A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients. Current Therapeutic Research, 19, 99–104.
Pouissant, A. F., & Ditman, K. S. (1965). A controlled study of imipramine (Tofranil) in the treatment of childhood enuresis. Journal of Pediatrics, 67, 283–290.
Puig-Antich, J., Perel, J. M., Lupatkin, W., Chambers, W. J., Tabrizi, M. A., King, J., Goetz, R., Davies, M., & Stiller, R. L. (1987). Imipramine in prepubertal major depressive disorders. Archives of General Psychiatry, 44, 81–89.
Rapoport, J. L., Buchsbaum, M. S., Weingartner, H., Zahn, T. P., Ludlow, C., & Mikkelsen, E. J. (1980). Dextroamphetamine: Its cognitive and behavioral effects in normal and hyperactive boys and normal men. Archives of General Psychiatry, 37, 933–943.
Rapoport, J. L., Mikkelsen, E. J., & Werry, J. S. (1978). Antimanic, antianxiety, hallucinogenic and miscellaneous drugs. In J. S. Werry (Ed.), Pediatric psychopharmacology: The use of behavioral modifying drugs in children (pp. 316–355). New York; Brunner/Mazel.
Rapoport, J. L., Mikkelsen, E. J., Zavadil, A., Nee, L., Gruenau, C., Mendelson, W., & Gillin, J. C. (1980). Childhood enuresis: II. Psychopathology, tricyclic concentration in plasma and antienuretic effect. Archives of General Psychiatry, 37, 1146–1152.
Ratey, J. J., Mikkelson, E., Sorgi, P., Zuckerman, S., Polakoff, S., Bemporad, J., Bick, P., & Kadish, W. (1987). Autism: The treatment of aggressive behaviors. Journal of Clinical Psychopharmacology, 7, 35–41.
Realmuto, G. M., Erickson, W. D., Yellin, A. M., Hopwood, J. H., & Greenberg, L. M. (1984). Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents. American Journal of Psychiatry, 14, 440–442.
Ritvo, E. R., Freeman, B. J., Yuwiler, A., Geller, E., Schroth, P., Yokota, A., Mason-Brothers, A., August, G. J., Klykylo, W., Leventhal, B., Lewis, K., Piggott, L., Realmuto, G., Stubbs, E. G., & Umansky, R. (1986). Fenfluramine treatment of autism: UCLA collaborative study of 81 patients at nine medical centers. Psychopharmacology Bulletin, 22, 133–140.
Rogers, W. J. B. (1965). Use of haloperidol in children’s psychiatric disorders. Clinical Trials Journal, 2, 162–165.
Satterfield, J. H., Cantwell, D. P., Schell, A., & Blaschke, T. (1979). Growth of hyperactive children treated with methylphenidate. Archives of General Psychiatry, 36, 212–217.
Shapiro, A. K., Shapiro, E., & Wayne, H. (1973). Treatment of Tourette’s syndrome. Archives of General Psychiatry, 28, 92.
Sheard, M. H. (1975). Lithium in the treatment of aggression. Journal of Nervous and Mental Disease, 160, 108–118.
Sheard, M. H., Marini, J. L., Bridges, C. I., & Wagner, E. (1976). The effects of lithium on impulsive, aggressive behavior in man. American Journal of Psychiatry, 133, 1409–1413.
Siassi, I. (1982). Lithium treatment of impulsive behavior in children. Journal of Clinical Psychiatry, 32, 34–42.
Simpson, G. M., Lee, J. H., Zoubok, B., & Gardos, G. (1979). A rating scale of tardive dyskinesia. Psychopharmacology (Berlin), 64, 171–179.
Wender, P. H., Wood, D. R., & Reimirer, F. W. (1985). Pharmacological treatment of attention deficit disorder, residual type (ADD, RT, “minimal brain dysfunction,” “hyperactivity”) in adults. Psychopharmacology Bulletin, 21, 222–227.
Werry, J. S., & Aman, M. G. (1975). Methylphenidate and haloperidol in children: Effects on attention, memory and activity. Archives of General Psychiatry, 32, 790–795.
Werry, J. S., Weiss, G., Douglas, V., & Martin J. (1966). Studies on the hyperactive child: III. The effects of chlorpromazine upon behavior and learning ability. Journal of the American Academy of Child Psychiatry, 5, 292–312.
Williams, D. T., Mehl, R., Yudofsky, S., Adams, D., & Roseman, B. (1982). The effects of propranolol on uncontrolled rage outbursts in children and adolescents with organic brain dysfunction. Journal of the American Academy of Child Psychiatry, 21, 129–135.
Wong, G. H., & Cock, P. J. (1971). Long-term effects of haloperidol on severely emotionally disturbed children. Australian and New Zealand Journal of Psychiatry, 5, 296–300.
Zesiewicz, M. F., Natta, M. B., & Kupst, M. J. (1987). Effects of psychiatric hospitalization and psychotropic medications on weight in children. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 854–857.
Zrull, J. P., Westman, J. C., Arthur, B., & Bell, W. A. (1963). A comparison of chlordiazepoxide, d-amphetamine, and placebo in the treatment of the hyperkinetic syndrome in children. American Journal of Psychiatry, 120, 590–591.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Small, A.M., Perry, R. (1989). Pharmacotherapy. In: Lyman, R.D., Prentice-Dunn, S., Gabel, S. (eds) Residential and Inpatient Treatment of Children and Adolescents. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0927-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0927-5_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0929-9
Online ISBN: 978-1-4899-0927-5
eBook Packages: Springer Book Archive